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Abstract
Background: To increase adherence rate to recommendations for follow-up after abnormal
colorectal cancer (CRC) screening results, factors that inhibit and facilitate follow-up must be
identified. The purpose of this study was to identify the factors associated with intention to adhere
to CRC screening follow-up exams.
Methods: During a 4-week period in October 2003, this survey was conducted with 426 subjects
participating in a community-based CRC screening program in Nagano, Japan. Study measures
included intention to adhere to recommendation for clinical follow-up in the event of an abnormal
fecal occult blood test (FOBT) result, perceived susceptibility and severity of CRC, perceived
benefits and barriers related to undergoing follow-up examination, social support, knowledge of
CRC risk factors, health status, previous CRC screening, personality and social demographic
characteristics. Univariate and multivariate logistic regression analyses on intention to adhere to
recommendations for follow-up were performed.
Results: Among the 288 individuals analyzed, approximately 74.7% indicated that they would
definitely adhere to recommendations for follow-up. After controlling for age, gender, marital
status, education, economic status, trait anxiety, bowel symptoms, family history of CRC, and
previous screening FOBT, analyses revealed that lower levels of perceived barriers, higher levers
of perceived benefits and knowledge of CRC risk factors were significantly associated with high
intention respectively.
Conclusion: The results of this study suggest that future interventions should focus on reducing
modifiable barriers by clarifying misperceptions about follow-up, promoting the acceptance of
complete diagnostic evaluations, addressing psychological distress, and making follow-up testing
more convenient and accessible. Moreover, educating the public regarding the risk factors of CRC
and increasing understanding of the benefits of follow-up is also important.
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Background
The incidence and mortality rates of colorectal cancer
(CRC) have increased markedly in Japan. Age-adjusted
death rates of CRC have doubled during the past few dec-
ades, from 8.6 and 7.5 per 100,000 males and females
respectively, in 1950 to 22.8 to 13.5 per 100,000 in 2003
[1]. 5-year survival rates for CRC vary dramatically accord-
ing to the stage of detection from 25% when there is dis-
tant spread of the disease, to 95% when the disease is
localized [2]. Thus, the prevention and early detection of
CRC is of great public health importance.
Screening using the fecal occult blood test (FOBT) has
been shown to reduce the incidence and mortality of CRC
in randomized clinical trials [3]. In addition, results from
case-controlled studies have suggested that screening
using immunochemical FOBT could reduce mortality
from CRC by 60% or more for Japanese populations aged
40 year and older who screen annually [4]. Patients with
an abnormal FOBT (FOBT+) in these trials were routinely
followed up with a complete diagnostic evaluation
(CDE), and the reduction in mortality demonstrated in
FOBT screening trials can be attributed to the use of fol-
low-up CDE. According to the Japanese Ministry of Health
and Welfare's CRC screening guidelines, CDE includes
colonoscopy or the combination of a double air contrast
barium enema X-ray and flexible sigmoidoscopy, or in
cases where an endoscopy cannot be completed, a double-
contrast barium enema examination is also temporarily
acceptable [5].
Under the auspices of the Health and Medical Service Law
for the Aged, a national CRC screening program was initi-
ated in Japan in 1992 as part of a public health policy.
Asymptomatic populations over the age of 40 are recom-
mended to participate in the screening program, which
uses a 2-day immunochemical FOBT. Despite strong con-
sensus from public health academics and cancer epidemi-
ologists in supporting CRC screening, fewer than 60% of
screening FOBT+ patients received follow-up evaluation,
and this poor follow-up rate remained unchanged
between 1992 and 2003 [6]. Limited follow-up rates pose
an important obstacle to achieving overall CRC screening
effectiveness. Moreover, non-adherence to CDE has been
implicated as contributing to adverse outcomes in retro-
spective analysis of advanced CRC [7]. It remains a matter
of urgency to improve clinical follow-up compliance.
Therefore, to assist in the development of effective inter-
ventions, studies which provide knowledge regarding the
factors that facilitate or impede clinical follow up positive
FOBT results are needed.
Inadequate follow-up of FOBT+ patients have also been
reported in the United States [8-13]. Recently, Nadel and
colleagues have showed that 31.6% of the FOBT+ patients
did not have any follow-up exams. Previous studies have
focused on physicians' potential barriers and facilitating
factors implicated in the provision of follow-up exams
[10-16], including physicians' background (e.g., board
certification, time in practice, specialty, etc.), cognitive
and psychosocial representations (e.g., perceived CDE
effectiveness, belief that CDE is standard practice, inten-
tion to evaluate a FOBT+ with CDE, concerns about CDE
related cost, etc.), practice environment (e.g., number of
physicians, etc.) and patient characteristics. Regarding
patient characteristics, being a male [12], having high
social class [16], with the greater number of positive
Hemoccult windows, having family history of CRC,
patients' CRC worry [10], and consultation with a gastro-
enterologist [8] have been reported to improve physi-
cians' chances to order an adequate follow-up evaluation.
Non-adherence is perceived to be a global problem, in
that both providers and patients appear to share responsi-
bility for the problem [11,14,16,17]. Very little, if any, few
published studies focus on factors impacting on FOBT+
patients' decisions to undergo follow-up examinations.
Previous research has suggested that noncompliant
FOBT+ patients reported time restraints and an absence of
current symptoms as major reasons for failure to undergo
clinical follow-up after a positive FOBT [18]. However, it
must be noted that the study sample employed was small
and that the research methodology used descriptive meth-
ods only. Recently, Tashiro reported that in comparison
with patients who complied with follow-up recommen-
dations, noncompliant patients who were 70 years and
older demonstrated worse mental health status and phys-
ical functioning [19]. However this study included a
methodological limitation in that it measured the FOBT+
patients' quality of life only. In order to target patient edu-
cation and intervention strategies to improve quality of
care for patients with abnormal FOBT, and ultimately to
decrease non-compliance to clinical follow-up recom-
mendations, it is important to understand the characteris-
tics motivating and inhibiting patients compliance with
clinical follow-up recommendations.
Conceptual framework (Fig. 1)
In order to contribute to intervention design, this study
examined the factors that may impact intention to comply
with clinical follow-up recommendations. We incorpo-
rated elements of the Health Belief Model (HBM) [20,21]
and the Theory of Planned Behavior [22] to direct the
present research. According to the Theory of Planned
Behavior, one of the strongest immediate determinants of
behavior is a person's intention to perform it. Empirically,
intention to undergo screening remains one of the strong-
est and most consistent factors associated with actual can-
cer preventive behavior, including breast [23,24], prostateBMC Public Health 2006, 6:272 http://www.biomedcentral.com/1471-2458/6/272
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[25], cervical [24], and colon [26,27] cancer screening.
The main outcome of variable of this study was intention.
The present study used four original constructs from HBM
as identifying factors that may facilitate or restrain follow-
up intention. According to the original HBM, a person's
decision regarding undertaking a preventive action related
to a disease is influenced primarily by the following four
beliefs: (a) perceived susceptibility (one's opinion of the
chances of getting a condition), (b) perceived severity
(one's opinion of how serious a condition and its seque-
lae are), (c) perceived barriers (one's opinion of the tangi-
ble and psychological costs of the advised action), and (d)
perceived benefits (one's opinion of the efficacy of the
advised action to reduce risk of seriousness of impact).
Furthermore, knowledge regarding cancer [28-31] and
social support from family and/or the health care profes-
sionals [32-37] that have been shown to be related or
associated with screening behavior and intention were
also included in our framework.
Methods
Setting
The study was conducted in S City in the Nagano Prefec-
ture located in the center of Japan, northwest of Tokyo.
The city has a population of approximately 67,800. FOBT
screening is conducted at the A public hospital of S City
throughout the year. Once a year in March, the city office
distributes information regarding CRC screening to eligi-
ble inhabitants using a pre-paid pre-addressed postcard.
Applicants select the day that suits them, and return the
postcard to the City Health Department. Two weeks
before the screening date, FOBT kits are mailed to perspec-
tive participants. Kits also contain printed instructions for
specimen collection and applicator sticks. Screening par-
ticipants are required to conduct the specimen collection
at home and to return completed kits to A public hospital
on the day of screening when participants will undergo
consultation with a physician.
Participants are notified of test results by written corre-
spondence 2 weeks later after undertaking the test. Partic-
ipants testing positive are informed that their FOBT tested
positive and that they should undergo further testing. In
order to ensure follow-up for FOBT+ participants, two
kinds of forms are enclosed with this letter. The first is a
letter of introduction for clinical examination to be given
to the medical institution. The other sheet requests per-
mission for the hospital where the patient receives follow-
up examination to forward on the results to S City Health
Department. If the follow-up related information is not
received within three months, public health nurses of the
Health Department contact patients to encourage follow-
up adherence by letter and telephone. Based on adminis-
trative data, approximately 4,320 people undertook FOBT
screening in 2002 and of these 347 patients were found to
have abnormal test results, of which 227 (65.4%) received
further clinical evaluation.
Procedure
Participants for this study were CRC screening partici-
pants recruited at the screening department of A public
hospital. We handed letters requesting participation in the
study to all participants attending the hospital for screen-
ing, after obtaining oral consent to participate in the
study, willing respondents were asked to complete the
anonymous questionnaire in the waiting room before
consulting with the physician. Respondents were pro-
vided with pencils and clipboards to fill out the question-
naire, which required approximately 20 minutes to
complete on average. The data collection covered a 4-
week period in October 2003. The total number of CRC
screening participants in the study period was 426.
In order to help respondents distinguish CRC screening
exams options, the survey provided descriptions regarding
the methods of CDE and the rate of FOBT+ results before
undertaking the survey. To avoid influencing respondents'
perceptions [38], we used the standard letter recommend-
ing follow-up and an information brochure about CRC
screening, both of these are currently used in Japanese
community-based cancer screening program, as routine
procedure for distributing information. These informa-
tion materials showed and explained the procedures,
however did not include information regarding the bene-
fits, costs, potential uncertainties and limitations of each
test, therefore we also decided not to offer those informa-
tion.
Ethical considerations
During this study period, the University of Tokyo did not
require ethical approval for anonymous questionnaire
studies. After reviewing from the A public hospital and the
Health Department of S City, the written authorization to
conduct this study was obtained from the Mayor. Care
was taken to minimize the burden on participating
patients in terms of physical disruption and emotional
disturbance. Participants were informed of their freedom
to participate or to withdraw from the research and efforts
were made to maintain privacy.
Subjects
A total of 405 participants indicated a willingness to par-
ticipate in the study. Those who declined participation
gave reasons such as being uninterested (n = 8) and feel-
ing unwell (n = 13). No data are available concerning on
non-responders.BMC Public Health 2006, 6:272 http://www.biomedcentral.com/1471-2458/6/272
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Development of the study questionnaire
Survey development was based on the review of literatures
and the researchers' research and clinical experiences as
general hospital interns.
Dependent variables
This study employed the concept of behavioral intent as a
dependent variable. We assessed intention to adhere to
the recommendation for follow-up consultation in the
event of an abnormal FOBT result in terms of response to
the following scenario presented in the questionnaire,
which states: "Today, you undertook a FOBT screen test,
and you will subsequently be given a result that indicates
a normal or an abnormal result. If you are informed that
you had a positive FOBT and that you should go to hospi-
tal for further testing, how likely is it that you will do
this?". The response categories used a five-point Likert-
type scale ranging from definitely (5); probably (4); not
sure (3); probably not (2); to, definitely not (1).
Responses were dichotomized as 5 versus the responses
less then 5. Respondents with a score of 5 were classified
as having strong intention to undertake the recom-
mended follow-up in the event of an abnormal FOBT
result and were compared with respondents scoring < 5,
who were classed as having weaker intention. Use of these
categories is consistent with the approach suggested by
Manski [39] who recommended that intention should
describe the strongest probability of behavior completion.
This categorization has been used in previous studies
looking at intentions regarding undertaking CRC screen-
ing [27,33], and prostate cancer screening [34].
Predictor variables
This study used items adapted from Jacobs' revised Cham-
pion's Health Belief Model Scales [40] modifying them to
measure perceived susceptibility and severity of CRC, and
perceived benefits of undergoing follow-up exams. The
subscales were translated using a back-translation tech-
nique. Six bilingual health professionals in the research-
ers' health education department conducted the
translation into Japanese, ascertained the subscales' con-
tent validity, and determined the cultural appropriateness
of the tool. A different bilingual individual then back
translated the Japanese version into English. Relevance
and accuracy were checked by a double translation and
subsequent comparison of two English versions. All items
for these subscales consisted of belief statements with a 5-
point Likert scale ranging from strongly disagree (1) to
strongly agree (5). Before the study, the test-retest reliabil-
ity of the translated survey was pre-tested in 40 subjects
with a 2 – 3 week interval between tests. The test-retest
correlations ranged from r = 0.73 to 0.89.
Perceived susceptibility
Perceived susceptibility was assessed to rate one's chance
of getting CRC. With respect to absolute risk, two items
were asked to the respondents 'how likely are you to get
CRC in the next few years and in lifetime?' For compara-
tive risk, one item was asked respondents 'compared with
other people of your age, how likely are you to get CRC in
the lifetime?' Higher scores indicate a higher perceived
risk of developing CRC, internal reliability in the present
sample was α = 0.85.
Perceived severity
Participants' beliefs regarding the severity of CRC were
measured by 6 items. Items assessed how severely CRC
would disrupt personal health, emotional well-being, and
overall severity of the health consequences. Higher scores
indicate higher perceived severity of CRC, internal relia-
bility in the present sample was α = 0.83.
Perceived benefits
The words "have regular check-ups to detect colon cancer"
were changed to "undergo follow-up examination to
detect CRC", and 6 items were included in this revised
subscale. Items included concerned respondent's beliefs
regarding the follow-up examination's effectiveness and
attributes: finding CRC and/or polyps early, decreasing
the chances of dying from CRC, and freedom from worry
about CRC. Higher scores indicate a higher perceived ben-
efit of CDE, and internal reliability in the present sample
was α = 0.88.
Perceived barriers
Perceived barriers were measured using 11 items (Table
2). The constructs of perceived barriers to follow-up exam-
ination were developed by an extensive review of the liter-
ature on CRC endoscopic screening specifically
[28,30,31,36,41-51], as well as follow-up of abnormal
cervical [35,52,53], prostate [54] and breast cancer screen-
ing [55-57]. We estimated four domains of barriers; mis-
perception regarding the necessity of follow-up (n = 2),
discomfort with the CDE procedure (n = 4), psychological
costs (n = 2), and practical barriers (n = 3). Respondents
were asked to indicate the extent to which they strongly
disagree (1) or strongly agree (5) with each of the items.
Since the various potential barriers were not relative [21],
these item sets did not form reliable scales according to
scaling criteria, and analysis was conducted on the indi-
vidual items.
Social support
Social support was investigated using the following ques-
tions: (1) "If you had a health problem would you be able
to talk about it with family members"; and (2) "Would
you be able to talk about the health problem with healthBMC Public Health 2006, 6:272 http://www.biomedcentral.com/1471-2458/6/272
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care professionals easily?" Responses were recorded as yes
(1) and no (0).
Knowledge of CRC risk factors
Items were modified from previous studies [31,58,59].
Participants were asked, "Do you know if the following
things increase a person's chance of getting CRC?"
Response choices included: (1) increasing age; (2) having
a blood relative with bowel cancer; (3) low-fiber diet; (4)
high-fat diet. The correct answer was scored as 1 and
incorrect responses and missing data were scored as 0.
Knowledge of risk factors was assessed after assessing per-
ceived susceptibility.
Health status
Several measures of health status were used in this study.
(1) Family history of bowel cancer: respondents were
asked if any of their first-degree blood relatives had expe-
rienced CRC. (2) Respondents were asked if they had
experienced any of the following bowel symptoms: con-
stipation, use of laxatives, diarrhea, wind, pain in the
abdomen, incontinence, blood, hemorrhoids, indiges-
tion, and anal soreness. Each was rated for frequency dur-
ing the past year (non-existent, occasionally, frequently).
Responses were dichotomized as "having at least one
symptom occasionally or frequently = 1" and "not = 0" for
analysis. In addition, subjective health status, the exist-
ence of chronic conditions and bowel disease history were
also asked.
Past CRC screening
Subjects were asked if they had ever undertaken FOBT,
when they had been tested, if their FOBT had ever been
abnormal, if follow-up had ever been recommended, or if
they had ever had undergone a previous CDE. In addition,
respondents were asked if they had received a CDE diag-
nosis outside of regular CRC screening.
Personality
Only the 20-item subscale of Japanese standardized Trait
Anxiety Inventory was used in this study [60,61]. Internal
reliability in the present sample was α = 0.86.
Socio-demographic characteristics
Demographic information was sought including age, gen-
der, marital status, living arrangement, education (level of
school completed), employment status, and subjective
economic status.
Data analysis
The experience of having had abnormal cancer screen
results may influence patients' beliefs, knowledge, and
compliance regarding future cancer screening [30,50,62].
In order to determine follow-up intention, it was deemed
inappropriate to analyze persons who had and had not
experienced previous follow up together. Therefore those
participants who indicated that they had previously
received bowel examination (e.g., CDE as well as flexible
sigmoidoscopy or barium enema X-ray only) (n = 88),
and those who were recommended but did not adhere to
follow-up tests (n = 9) were not included in the analyses.
Furthermore, individuals with a personal history of CRC
(n = 4) and respondents with insufficient data on key var-
iables on intention (n = 16) were excluded. Thus, the
remaining 288 subjects formed the group focused on by
this study.
Descriptive statistical data were used to summarize partic-
ipant characteristics. Initially, logistic regressions were
conducted to assess the independent effect of each study
variable's association with follow-up intention. Further-
more, multivariate logistic regression analyses were con-
ducted using age, gender, marital status, education, self-
rated economic status, trait anxiety, bowel symptoms,
family history of CRC and past FOBT screening as control
variables, the social and psychosocial variables (e.g., per-
ceived barriers, perceived benefits, perceived susceptibil-
ity, perceived severity, knowledge of CRC risk factors, and
social support) were entered individually into the model
to determine whether they had significant association
with intention. The unadjusted and adjusted odds ratio
described the association of each psychosocial variable
and intention respectively. The statistical package SPSS
(Version 11.5J) was used for the analysis. An alpha level
of 0.05 was used to determine the statistical significance
for all analyses, and all p values were assessed using two-
sided tests.
Results
Characteristics of study participants (Table 1)
Information regarding the 288 subjects in the study is pre-
sented in Table 1. Approximately one quarter of subjects
(23.8%) were less than 50 years of age and 20.2% were
greater than 70 years of age. Due to the fact that employed
workers can receive cancer screening through occupa-
tional health insurance, only one third of subjects were
men (33.0%). Most subjects were currently married
(89.0%) and living with a family member (94.2%). The
majority did not have education beyond high school
(72.4%). Approximately 60.8% were employed on a full
time or a part-time basis. Approximately two-thirds indi-
cated that their economic status was average.
The mean score on the Trait Anxiety subscale was 43.9
(8.7). Approximately one half of the sample rated their
general health as fair, 31.6% as good or very good,
approximately 44.8% reported having chronic disease.
Approximately 55.3% had at least one bowel symptom,
but none of the respondents reported having ever been
diagnosed with any of the bowel diseases previouslyBMC Public Health 2006, 6:272 http://www.biomedcentral.com/1471-2458/6/272
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listed. The percentage of respondents who had one or
more first-degree relatives with bower cancer was 14.2%.
Approximately 69.3% had previously undertaken at least
one FOBT screening test.
Social-psychosocial profiles of study participants (Table 2)
Perceived barriers
The score of the barriers ranged from 1.4 (0.9) to 3.8
(1.3). In order to shed light on the nature of barriers to
explore these factors in more detail, we analyzed the per-
centage of respondents who "strongly agreed or agreed"
with each item. Regarding misperceptions, "unnecessary
unless symptomatic" (11.4%), and "unnecessary for my
age" (8.9%) were also reported in low ratios. A cluster of
CDE procedure related discomfort barriers were com-
monly cited as follows, in order of preference: concerns
about "bowel preparation" (70.9%), "pain" (63.6%),
"discomfort" (64.5%), and "embarrassment" (39.6%).
Regarding psychological costs, if notified of an abnormal
FOBT result, 62.7% of the sample reported that they were
afraid that the follow-up check would find cancer, and
37.5% of the sample identified discomfort to talk about
CRC. Moreover, responses to practical barriers were low
including "too busy" (9.3%), "cost" (8.5%), and "having
other important things to do" (3.6%).
Perceived benefits
Six items measured the benefits of undertaking follow-up
tests and the average score was high 25.0 (5.5) with
respondents universally agreeing with most of the listed
benefits: "will help find polyps" (89.8%), "will help find
CRC early" (86.3%), "reduce uncertainty" (83.9%), "relief
from fear of getting CRC" (72.4%), and "decrease the
chance of dying from CRC" (75.7%). The lowest percent-
age of agreement was the item "having CDE decreases my
chances of requiring radical or disfiguring surgery"
(59.4%).
Perceived susceptibility
The average susceptibility score was 6.3 (2.7). A minority
of respondents (8.9%) reported that "my risk is higher
than other people of my age" and 14.5% reported, "It is
possible that I could get CRC". Respondents with family
history of CRC were more likely to rate them at higher risk
(p < 0.001), although most still rated their risk of bowel
cancer as average or even below average.
Perceived severity
The average seriousness score was 19.0 (5.9). The majority
of respondents (68.3%) indicated that "even if CRC were
detected the sequelae would last a long time", and 53.2%
agreed that "the thought of getting CRC scares me".
Women perceived CRC as more severe than men (p =
0.001). Furthermore, having bowel symptoms were asso-
ciated with high levels of perceived seriousness (p =
0.001).
Knowledge of CRC risk factors
Approximately 45.8% of respondents recalled older age as
a risk factor for CRC. Family history of CRC was men-
tioned by 77.1%. Lifestyle factors were recalled with
greater frequency (low fiber diet = 91.5%; high fat diet =
85.6%). Approximately one third (29.9%) of respondents
were able to recall all four risk factors for CRC.
Social support
More than one half (53.1%) of all subjects indicated that
family members were likely to support them in the event
Table 1: Characteristics of study sample (n = 288)
Variable % or mean(SD)
Sociodemographic characteristics
Age
< 50 23.8
50–59 27.7
60–69 28.3
>=70 20.2
Gender
Men 33.3
Marital status
Married 89.0
Living arrangement
Living alone 5.8
Spouse/partner only 37.5
With children 35.5
With parents (and children) 20.9
Education
Less than high school 10.3
High school 62.1
Junior college/technical school 17.7
College degree or higher 9.9
Employment status
Employed 60.8
Self-rated economic status
Indigent/somewhat indigent 16.3
Average 69.1
Affluent/somewhat affluent 14.5
Personality
Trait anxiety (20 – 80) 43.9(8.7)
Health status
Subjective health
Good/very good 31.6
Fair 55.6
Poor/very poor 12.8
Have chronic disease
Yes 44.8
Have bowel symptoms
Yes 53.8
Family history of CRC
Yes 14.2
Past FOBT screening
Yes 69.3
Note: CRC, colorectal cancer; FOBT, fecal occult blood test.BMC Public Health 2006, 6:272 http://www.biomedcentral.com/1471-2458/6/272
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of illness, and 55.9% of subjects said that they could com-
municate about the problem with health care profession-
als easily.
Intention to adhere to follow-up recommendation (Table 
2)
The majority (74.7%) of respondents expressed high
intention, i.e., indicated that they would definitely adhere
to follow-up recommendations after a hypothetical
abnormal CRC screening result. None of the socio-demo-
graphic variables, health status related variables or trait
anxiety was significant predictors of intention (data no
shown). After controlling for age, gender, martial status,
education, self-related economic status, trait anxiety,
bowel symptoms, family history of CRC and past screen-
ing FOBT, the multivariate logistic regression analyses
revealed that lower perceived barriers, higher perceived
benefits and knowledge of CRC risk factors were signifi-
cantly associated with intention separately. However, per-
ceived susceptibility, perceived severity and social support
were not statistically associated with intention in bivariate
and multivariate analyses.
Discussion
To the best of our knowledge, the present study is the first
investigation into the factors relating to adherence to rec-
ommendations for clinical follow-up after an abnormal
screening FOBT result. This theory-driven research
presents useful findings that have not been previously
investigated. Among the 288 individuals analyzed, 74.7%
indicated that they would definitely adhere to recommen-
dations for follow-up, we identified that higher perceived
barriers were significantly associated with lower inten-
tion, and that high-perceived benefits and greater knowl-
edge of CRC risk were associated with increased intention.
In the following discussion we discussed in accordance
with Table 2.
Several studies published to date have widely used HBM
or part of HBM to design theoretical framework to facili-
Table 2: Logistic regression of intention to adhere to recommendations for follow-up after an hypothetical abnormal FOBT result (n = 
288)
Bivariate analyses Multivariate analyses
respondents crude adjusteda
Variables range or category % or mean(SD) OR(95%CI) p value OR(95%CI) p value
Intention high 74.7
Perceived barriers
Misperception regarding the necessity of follow-up
CDE are not necessary unless symptomatic 1 – 5 1.8(1.2) 0.70(0.56–0.87) 0.002 0.67(0.53–0.85) 0.001
CDE are not necessary for my age 1 – 5 1.7(1.1) 0.64(0.51–0.81) < 0.001 0.60(0.47–0.77) < 0.001
Discomfort with the CDE procedure
Having CDE would be embarrassing 1 – 5 2.8(1.5) 0.85(0.70–1.02) 0.072 0.76(0.62–0.94) 0.010
Bowel preparation for the CDE is too difficult 1 – 5 3.8(1.3) 1.11(0.90–1.37) 0.316 1.06(0.85–1.33) 0.589
Having CDE would be uncomfortable 1 – 5 3.6(1.4) 0.97(0.80–1.18) 0.763 0.91(0.73–1.13) 0.403
Having CDE would be painful 1 – 5 3.6(1.4) 0.98(0.81–1.20) 0.870 0.91(0.73–1.13) 0.410
Psychological costs
I will feel uncomfortable talking about CRC 1 – 5 2.7(1.4) 0.84(0.69–1.02) 0.073 0.80(0.65–0.99) 0.037
I am afraid of finding cancer 1 – 5 3.5(1.4) 0.92(0.76–1.12) 0.435 0.86(0.72–1.09) 0.250
Practical barriers
I am too busy to undertake follow-up examinations 1 – 5 1.8(1.1) 0.54(0.42–0.70) < 0.001 0.48(0.36–0.63) < 0.001
I have other things to do that are more important than 
undertaking follow-up examinations
1 – 5 1.4(0.9) 0.59(0.44–0.79) < 0.001 0.56(0.41–0.76) < 0.001
Having CDE would cost too much money 1 – 5 1.8(1.1) 0.75(0.59–0.95) 0.016 0.71(0.54–0.92) 0.009
Perceived benefits 6 – 30 25.0(5.5) 1.07(1.02–1.12) 0.008 1.06(1.02–1.12) 0.010
Perceived susceptibility 3 – 15 6.3(2.7) 1.02(0.92–1.12) 0.744 1.05(0.94–1.17) 0.377
Perceived severity 6 – 30 19.0(5.9) 1.04(1.00–1.09) 0.071 1.05(0.99–1.10) 0.094
Knowledge of CRC risk factorsb
Blood relative with CRC correct 77.1 2.04(1.10–3.77) 0.023 2.06(1.07–4.12) 0.030
Low fiber diet correct 91.5 2.49(1.04–5.96) 0.041 2.72(1.07–6.90) 0.035
High fat diet correct 85.6 1.52(0.74–3.14) 0.258 1.33(0.60–2.95) 0.491
Increasing age correct 45.8 1.20(0.69–2.07) 0.515 1.22(0.69–2.12) 0.486
Social supportc
Health care professionals yes 55.9 1.12(0.65–1.92) 0.695 1.15(0.65–2.05) 0.633
Family members yes 53.1 1.04(0.59–1.85) 0.884 0.96(0.53–1.75) 0.902
Note: OR: odds ratio; CI, confidence interval; CDE, complete diagnostic evaluation; CRC, colorectal cancer; FOBT, fecal occult blood test.
a adjusted for age, gender, marital status, education, economic status, trait anxiety, bowel symptoms, family history of CRC, and past FOBT screening. b correct vs. else. c yes 
vs. not.
For the scales, the OR estimate the change in odds of intention that is associated with a change of one scale point.
The OR described the associated of each psychosocial variable and intention respectively.BMC Public Health 2006, 6:272 http://www.biomedcentral.com/1471-2458/6/272
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tate understanding of CRC screening interests
[31,33,36,37,46,51] and behaviors [28,30,42-44]. During
the past decade, HBM has also been used to investigate
Japanese stomach cancer screening behavior [62] and pre-
ventive health behaviors [32]. Despite variations in study
design and measurement of cancer screening attitudes and
behaviors, considerable support for the HBM has been
documented. In this study, perceived barriers and per-
ceived benefits were found to significantly associate with
intention, our findings suggest that the HBM provide a
useful framework for understanding patients' attitudes
and beliefs regarding follow-up for abnormal CRC screen-
ing results.
Barriers to performing recommended behaviors are one of
the key components in the HBM and have been shown to
be strong predictors of taking action [21,63]. We assessed
the four aspects of barriers, and our findings will help cli-
nician and researchers to develop effective interventions
to increase patients' compliance with recommendations
for further diagnostic follow-up.
The misconception held by respondents that follow-up
consultations were "unnecessary unless symptomatic"
and "unnecessary for my age" reflect lack of adequate
understanding regarding the purpose of screening to
detect CRC or polyps at an asymptomatic stage [42].
Respondents may lack understanding of the meaning of
positive FOBT results [35,64], misinterpret recommenda-
tion [35], or lack of distinction regarding asymptomatic
screening versus diagnostic testing [65]. In addition, we
suggested that age accounted for nonparticipation in the
following two ways: (1) that the young may perceive that
only older people need follow-up examination, and (2)
the older may believe that they are too old and too close
to death to look for illness [66]. Based on previous stud-
ies, lack of understanding of the necessity for follow-up
tests were also found among participants of breast [55]
and cervical cancer screening studies [35,52,53], and non-
compliance was attributed to lack of adequate communi-
cation regarding screening results [35] and necessity for
follow-up testing [64]. Misperception may lead some
patients to belief findings are normal and do not require
further attention [17]. Although follow-up guidelines for
abnormal FOBT have greater consensus and less variation,
Japanese cancer screening programs currently use a
generic letter providing information regarding screening
results and notification for follow-up. Since a well-
informed screening participant may be more likely to fol-
low up promptly after an abnormal screening result [57],
improving communication of the meaning of positive
screening results, the purpose and necessity of follow-up
examination, and clarifying misperceptions regarding fol-
low-up may be important components for further inter-
ventions.
Perceived unpleasantness regarding preparation for CDE
and discomfort of CDE procedures have also been identi-
fied as barriers to compliance with endoscopic screening
[28,30,31,36,37,41,42,44,45,47,48,50,67]. Despite lack
of experience, the majority of subjects thought that proce-
dure of CDE was uncomfortable. Results from the current
sample are partially inconsistent with the literature, in
that we observe significant association of perceived
embarrassment and intention. It may be that since these
patients already understood that CDE is invasive and
unpleasant, they had already anticipated a certain degree
of pain or discomfort but believed they could cope. In
fact, patient who had undergone endoscopy examination
found that the procedure more comfortable than expected
[68,69]. Nevertheless, combined with effects to improve
technical skills making CDE comfortable, health provid-
ers should assist patients in accepting the CDE [47].
If notified of abnormal FOBT results, a very high percent-
age of respondents perceived that they were "afraid of
finding cancer", and after controlling co-variables, the
perception of "uncomfortable talking about CRC"
showed a negative association with intention. The psycho-
logical impact of abnormal cancer screening results, such
as fear of diagnostic test, anxiety and worry about cancer
were indicated in the literature regarding follow-up of cer-
vical [53,70,71], breast [56,57,72] and prostate cancer
screening [54]. Abnormal cancer screening findings and
recalls for further investigation have the potential to gen-
erate psychological distress, and may be one reason of
patients fail to undergo follow-up testing. Our findings
indicate that the recommendation letter and the commu-
nication regarding follow-up should be created cau-
tiously; as such communication will elicit and address
patients' concern. Patients with special concerns or ques-
tions should be encouraged to contact the screening pro-
vider.
As well as findings in the FOBT and/or endoscopy screen-
ing for CRC [31,36,41,47,65,73], respondents identified
time constraints such as "being busy" or "having other pri-
orities" to undergo follow-up check. Compared with
FOBT screening, follow-up employing CDE is much more
demanding and invasive. Motivation and time is required
for proper bowel preparation, and undertaking the test
usually necessitates time off work for the participant. In
Japan there are local variations in the capacity of conduct-
ing endoscopic diagnostic examinations for positive
FOBT [74], difficulties in obtaining consultation and long
waiting periods for follow-up medical appointments have
interdependent effects on the risk for noncompliance
[75], thus shortening the interval from screening to diag-
nostic examination, making follow-up testing more con-
venient and accessible may help to motivate those
persons to overcome competing demands [52,55,73]. ABMC Public Health 2006, 6:272 http://www.biomedcentral.com/1471-2458/6/272
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few case studies have suggested that diagnostic examina-
tion in CRC screening were improved by reducing incon-
venience barriers [75], the intervention efficiency requires
further evaluation more thoroughly using studies with a
randomized controlled design. Our study also identified
that the necessity to pay out-of-pocket patients' costs con-
stitutes a barrier to intention. Fees for screening are par-
tially met by the local government, and fees for follow-up
tests are partially subsidized by patients' health insurance.
For example, individual payment for FOBT screening is
only about 800 yen (approximately US$ 7) and individ-
ual payment for colonoscopy is approximately 7,500 yen
(approximately US$ 65), with other costs (e.g., colono-
scopic polypectomies) running to approximately 24,000
yen (approximately US$ 209). Previous research sug-
gested that being uninsured or underinsured was associ-
ated with delayed or incomplete follow-up of cervical
cancer screening[17] and out-of pocket costs have influ-
enced patients' decision making [76], thus factors in will-
ingness to pay in encouraging follow-up for abnormal
FOBT screening is needed in the future.
In this study, patients with high-perception of benefits
were more likely to state that they intended to adhere to
follow-up recommendations than patients having low-
perception of benefits. These findings support a substan-
tial body of research on the association between benefits
and intentions in participating in cancer screening
[36,41]. In relation to a review of previous studies that
used constructs from the HBM, Janz and Becker indicated
that perceived benefits was a more important factor for
sick-role behaviors than for preventive health behavior
[63]. Follow-up examination appears to function more as
an early detection or sick-role behavior, where anticipated
benefits emerge as the stronger influencing factor [43].
Our findings can readily be interpreted within this con-
text. Although CRC screening has convincing evidence
regarding effectiveness, it appear that messages regarding
CRC screening exaggerate its potential benefits and fail to
mention the potential uncertainties (e.g., false-positive
results of FOBT) and limitations of CRC screening (e.g.,
false-negative results of FOBT and CDE), as well as the
possible complications associated with CDE (e.g., occa-
sional risk of perforation, bleeding, and cardio-respiratory
events from intravenous sedation). To better understand
the follow-up procedure and to obtain a truly informed
decision about CRC screening, we believe it is necessary to
promote more balanced information rather than a one
sided message, which states screening can only be univer-
sally beneficial [77,78].
Overall, the percentage of correct answers for knowledge
of CRC risk factors was high. We suggest that Japanese
people are highly aware of CRC as a result of 10-year
national CRC screening program. Screening participants
also appear to be relatively health-conscious and thus,
reported a greater knowledge of CRC. Similar to reports
from previous studies [29,31], few subjects are aware that
increasing age is a risk factor for CRC. This lack of aware-
ness may be explained by the suggestion that individuals
do not conceptualize unmodifiable characteristics (e.g.,
gender and age) as risk factors [29]. Knowledge may be
viewed as a distal predictor of intention, and in accord-
ance with other research results [31]; our findings demon-
strate that knowledge is positively associated with
intention. As knowledge of risk factors for cancer has
increased, the intention to undertake screening has
increased [29]; educating public regarding the risk factors
of CRC and increasing public awareness of CRC is
required. A limitation of the current study was a restricted
assess to knowledge of risk factors, thus further studies
should be conducted to provide insight into the other
domains of knowledge regarding CRC.
Perceived severity has a tendency to associate with inten-
tion, but failure to achieve statistical significance. Our
finding is not consistent with results from previous stud-
ies that have reported that perceived susceptibility has an
association with behavioral intention [33,36,44,50,67]. It
is possible that perceived susceptibility might be indi-
rectly connected to follow up intention mediated by the
others variables [36,79]. Social support was not a signifi-
cant predictor of intention in this study, and it may due to
the relative crudeness of our measurement. Furthermore
the sample in our investigation was homogenous, limit-
ing the ability to detect significant associations between
patients' characteristics and intention.
This study should be perceived as the first step concerning
the investigation of patients' factors potentially associated
with inadequate follow-up of abnormal FOBT screening.
Our findings should be interpreted in light of some
important limitations. Firstly, since this is a cross-sec-
tional study, a strong inference about causality cannot be
drawn. Secondly, intention was utilized as the outcome
variable in the present study. While a considerable body
of research supports the predictive validity of intentions
for a variety of behaviors, prospective studies should be
conducted to determine how well the variables identified
here, including intention, and other variables serve to pre-
dict actual compliance with follow-up tests. Thirdly, since
this sample was recruited from a single community the
generalization of findings is limited. Fourthly, since this
study examined patients' beliefs regarding CRC and fol-
low-up under a potentially abnormal FOBT, combined
with the limited sample size of patients who reported pre-
vious bowel examination was not possible, further
research is required to embrace those patients. Finally, the
schedule for this study did not allow time for a large pilot
study sample to establish reliability and validity of per-BMC Public Health 2006, 6:272 http://www.biomedcentral.com/1471-2458/6/272
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ceived barriers scales, and a recommendation for further
research would be for further analysis to be conducted
correlating social-psychosocial variables and intention in
one model simultaneously.
Conclusion
Despite a number of limitations, this theory-driven
research identified three factors that were significantly
associated with intentions to undergo follow-up exams:
perceived barriers, perceived benefits, and knowledge of
CRC risk factors. Ours findings suggest that future inter-
ventions should focus on reducing modifiable barriers by
clarifying misperceptions about follow-up, promoting the
acceptance of CDE, addressing psychological distress, and
making follow-up testing more convenient and accessible.
Moreover, educating the public regarding the risk factors
of CRC and increasing understanding of the benefits of
follow-up is also important. We believe that further
research is required to apply the findings from this study
to develop appropriate information and effective meth-
ods of communication and to identify the best strategies
for interventions.
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